Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study.

The Lancet. Haematology·2026
Same author

Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric Oncology.

medRxiv : the preprint server for health sciences·2026
Same author

Pediatric blastic plasmacytoid dendritic cell neoplasms are molecularly defined by recurrent <i>MYB</i> rearrangements: clinical and molecular insights.

Haematologica·2026
Same author

Parental Knowledge and Decisional Satisfaction Across Genomic Sequencing Consent Processes in Pediatric Cancer.

JCO oncology practice·2026
Same author

Novel <i>KAT6B::NUTM2B</i> fusion oncogene in congenital acute myeloid leukemia and implications for menin inhibitor therapy.

Haematologica·2026

Related Experiment Video

Updated: Jun 23, 2026

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

Quantifying interpretive contributions to analytical variability in clinical flow cytometry.

Paul E Mead1, Baptiste Labarthe2, Christy Embrey1

  • 1Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Cytometry. Part B, Clinical Cytometry
|June 22, 2026
PubMed
Summary

Human interpretation in flow cytometry causes variability in T-cell, B-cell, and natural killer cell (TBNK) counts, impacting CD4 classification. This operator-associated variability exceeds instrument differences, affecting clinical decisions.

Keywords:
CD4 enumerationTBNK immunophenotypingautomated analysisinterpretive variabilitymanual gatingmetrology

More Related Videos

Multicolor Flow Cytometry-based Quantification of Mitochondria and Lysosomes in T Cells
06:22

Multicolor Flow Cytometry-based Quantification of Mitochondria and Lysosomes in T Cells

Published on: January 9, 2019

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Related Experiment Videos

Last Updated: Jun 23, 2026

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

Multicolor Flow Cytometry-based Quantification of Mitochondria and Lysosomes in T Cells
06:22

Multicolor Flow Cytometry-based Quantification of Mitochondria and Lysosomes in T Cells

Published on: January 9, 2019

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Area of Science:

  • Clinical diagnostics
  • Immunophenotyping
  • Analytical chemistry

Background:

  • Reproducibility in clinical flow cytometry is critical for accurate patient diagnosis and monitoring.
  • Standardization efforts have minimized technical variability, but human interpretation during manual gating remains a significant source of error.
  • Threshold-based lymphocyte measurements, like absolute CD4 counts, are vital for clinical management and require high precision.

Purpose of the Study:

  • To quantify the variability introduced by human interpretation in routine clinical TBNK flow cytometry.
  • To assess the impact of interpretive variability on CD4 decision-band classification.
  • To establish a reference for analytical performance and evaluate deviations under routine conditions.

Main Methods:

  • A two-stage workflow audit using a fixed, automated analysis as a reference standard.
  • Analysis of standardized quality-control materials and 320 clinical samples by six technologists on three harmonized cytometers.
  • Definition of an empirical analytical performance envelope to evaluate routine testing deviations.

Main Results:

  • Under quality control, automated-manual differences were minimal and interpretable, with preserved CD4 classification.
  • Routine clinical samples exhibited significant variability, primarily driven by operator identity, not instrument differences.
  • Operator-associated variability was concentrated near CD4 thresholds, leading to discordant classifications.

Conclusions:

  • Human interpretation in manual gating is a significant, previously unquantified source of analytical variability in clinical flow cytometry.
  • This interpretive variability can impact threshold-based clinical classifications, such as CD4 counts, despite acceptable quality control.
  • Addressing operator variability is crucial for improving the reliability of flow cytometry results in clinical decision-making.